2001, DEA and Packaging - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

DEA

Packaging

3 New Federal Proposals Aimed at Cannabis, Psilocybin, and Hemp Reform

Veriheal

AUGUST 19, 2022

The committee recognizes that plastics are critical engineering materials for products ranging from food packaging and automobiles to medical devices. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes.

Hemp

Hemp DEA Access Cultivation

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

31) The United States DEA has stated that small amounts of other cannabinoids will also occur in all cannabis extracts, even those that purport to be CBD only – unless synthesized de novo, CBD isolate will always contain small amounts of THC when extracted from a plant. 25, November/December 2001. 32: United States DEA.

Extraction

Extraction Pharmaceutical CBD Epilepsy

3 New Federal Proposals Aimed at Cannabis, Psilocybin, and Hemp Reform

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Stay Connected